Clinical Trial

CHU Dual-Energy Ablation in Ventricular Arrhythmia

Study acronym: CHU-VA
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated March 31, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to evaluate the safety of the dual-energy ablation catheter manufactured by Shanghai MicroPort EP Medical Technology Co., Ltd. in the treatment of tachyarrhythmias.
Trial Details
NCT Number NCT07503769
Lead Sponsor Shanghai MicroPort EP MedTech Co., Ltd.
Conditions Premature Ventricular Contractions, Ventricular Tachycardia
Enrollment 10 participants
Start Date 2026-02-03
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-31